北京海王中新药业股份有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
156
NMPA:156
Drug Approvals
Ligustrazine Phosphate Tablets
- Product Name
- 磷酸川芎嗪片
- Approval Number
- 国药准字H20123072
- Approval Date
- Mar 29, 2022
NMPA
Oral Five Vitamins and Glucose
- Product Name
- 口服五维葡萄糖
- Approval Number
- 国药准字H11022247
- Approval Date
- Mar 11, 2022
NMPA
Aminopyrine，Caffeine and Calcium Glycerophosphate Tablets
- Product Name
- 氨咖甘片
- Approval Number
- 国药准字H13023466
- Approval Date
- Jul 9, 2021
NMPA
Paracetamol，Caffein，Atificial Cow-bezoar and Chlorphenamine Maleate Tablets
- Product Name
- 氨咖黄敏片
- Approval Number
- 国药准字H13023468
- Approval Date
- Jul 9, 2021
NMPA
Ethambutol Hydrochloride Tablets
- Product Name
- 盐酸乙胺丁醇片
- Approval Number
- 国药准字H13022185
- Approval Date
- Jul 9, 2021
NMPA
Aspirin Enteric-coated Tablets
- Product Name
- 阿司匹林肠溶片
- Approval Number
- 国药准字H13020602
- Approval Date
- Jul 9, 2021
NMPA
Ciprofloxacin Hydrochloride Tablets
- Product Name
- 盐酸环丙沙星片
- Approval Number
- 国药准字H13022182
- Approval Date
- Jul 9, 2021
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 16
- Next
Clinical Trials
No trials found
News
No news found